Company Profile

Aza Technology Inc
Profile last edited on: 7/10/24      CAGE: 7KF03      UEI: PSKJTVPT3169

Business Identifier: Point-of-care devices for diagnosing and managing hyperammonemia,
Year Founded
2016
First Award
2021
Latest Award
2021
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3416 Cork Oak Way
Palo Alto, CA 94303
   (443) 831-5394
   N/A
   www.azatechnology.com
Location: Multiple
Congr. District: 16
County: Santa Clara

Public Profile

A startup spun out of Stanford, Aza Technology is described as poised to deliver point-of-care device targeting diagnosis and management of hyperammonemia - responsible for a host of neurotoxic effects seen in Urea Cycle Disorder (UCD) and organic acidemia (OA) patients. Hyperammonemia is also referenced as a root cause of hepatic encephalopathy - a serious condition secondary only to alcoholic and non-alcoholic cirrhosis (NASH), resulting in over $2 billion in hospitalizations in the US alone. The foundational intellectual property under development at Aza Technology is described as enabling a home-use and point-of-care diagnostic device for evaluation of blood ammonia levels. In concert with their physicians, end-users would have capability to treat their own ammonia elevations with their choice of several safe and effective therapeutics.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2021 1 NIH $229,542
Project Title: Point-of-Care Blood Ammonia Measurement Using a Gas-Phase Fuel Cell Sensor

Key People / Management

  Thomas Richard Veltman -- CEO, President and CYO

Company News

There are no news available.